Aquestive Therapeutics (AQST) P/B (2018 - 2026)
Aquestive Therapeutics (AQST) P/B from Jul 25, 2018 to Jul 20, 2026. The TTM Aquestive Therapeutics (AQST) P/B is -14.40. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Aquestive Therapeutics (AQST)
| Year | P/B | Change |
|---|---|---|
| 2026 | -14.40 | -38.52% |
| 2025 | -23.42 | +332.99% |
| 2024 | -5.41 | +313.00% |
| 2023 | -1.31 | +190.70% |
| 2022 | -0.45 | -76.93% |
| 2021 | -1.95 | -48.79% |
| 2020 | -3.81 | -88.05% |
| 2019 | -31.92 | -304.62% |
| 2018 | 15.60 | N/A |
Comparison Aquestive Therapeutics (AQST) P/B with competitors
Aquestive Therapeutics (AQST) P/B is -14.40.